Ana Clara Patrício Barbosa

Ana Clara Patrício Barbosa

Auto-generated profile, based on publicly available information

Ana Clara Patrício Barbosa

Universidade federal do Pará

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2025 in Revista Brasileira de Cancerologia
Verified
Journal Article
Open access
PDF file
ABAna Clara Patrício Barbosa
Ana Clara Patrício Barbosa
CBCamila Carreira Brito
Camila Carreira Brito
GNGiovanna Gilioli da Costa Nunes da Costa Nunes
Giovanna Gilioli da Costa Nunes da Costa Nunes
NSNatasha Monte da Silva
Natasha Monte da Silva
JBJoão Victor Souza de Barros
João Victor Souza de Barros
NSNey Santos
Ney Santos
Introduction: Pancreatic cancer is one of the most aggressive malignancies, ranking as the twelfth most common cancer and the sixth leading cause of cancer-related deaths worldwide. Its etiology is multifactorial, involving both genetic and non-genetic factors. Objective: Investigate the relationship between epidemiological data on global incidence and mortality of pancreatic cancer and specific genetic variations known as single nucleotide polymorphisms (SNPs). Method: A total of 253 SNPs were analyzed, identified through genome-wide association studies (GWAS). Allele frequencies were obtained from global population databases. Pearson’s correlation analysis was utilized to evaluate the relationships between SNPs frequencies, incidence, and mortality rates. Results: The results identified 16 significant SNPs (p<0.05), among which rs2816938, rs372883, and rs2236575 were highly significant (p<0.001). These variants were primarily associated with higher mortality rates, particularly in European and American populations, while African and Southeast Asian populations showed lower SNPs frequencies and lower mortality rates. The findings suggest that genetic predisposition plays a crucial role in pancreatic cancer susceptibility and progression. Conclusion: The correlation between SNPs frequencies and epidemiological data reinforces the influence of population-specific genetic risk factors, highlighting the importance of personalized approaches in screening, prevention, and treatment strategies.

2 January 2026 in Revista Brasileira de Cancerologia
Verified
Journal Article
Closed access
ABAna Clara Patrício Barbosa
Ana Clara Patrício Barbosa
CBCamila Carreira Brito
Camila Carreira Brito
GNGiovanna Gilioli da Costa Nunes da Costa Nunes
Giovanna Gilioli da Costa Nunes da Costa Nunes
NSNatasha Monte da Silva
Natasha Monte da Silva
JBJoão Victor Souza de Barros
João Victor Souza de Barros
NSNey Santos
Ney Santos
Introduction: Pancreatic cancer is one of the most aggressive malignancies, ranking as the twelfth most common cancer and the sixth leading cause of cancer-related deaths worldwide. Its etiology is multifactorial, involving both genetic and non-genetic factors. Objective: Investigate the relationship between epidemiological data on global incidence and mortality of pancreatic cancer and specific genetic variations known as single nucleotide polymorphisms (SNPs). Method: A total of 253 SNPs were analyzed, identified through genome-wide association studies (GWAS). Allele frequencies were obtained from global population databases. Pearson’s correlation analysis was utilized to evaluate the relationships between SNPs frequencies, incidence, and mortality rates. Results: The results identified 16 significant SNPs (p<0.05), among which rs2816938, rs372883, and rs2236575 were highly significant (p<0.001). These variants were primarily associated with higher mortality rates, particularly in European and American populations, while African and Southeast Asian populations showed lower SNPs frequencies and lower mortality rates. The findings suggest that genetic predisposition plays a crucial role in pancreatic cancer susceptibility and progression. Conclusion: The correlation between SNPs frequencies and epidemiological data reinforces the influence of population-specific genetic risk factors, highlighting the importance of personalized approaches in screening, prevention, and treatment strategies.

2 January 2026 in Revista Brasileira de Cancerologia
Verified
Journal Article
Open access
PDF file
ABAna Clara Patrício Barbosa
Ana Clara Patrício Barbosa
CBCamila Carreira Brito
Camila Carreira Brito
GNGiovanna Gilioli da Costa Nunes da Costa Nunes
Giovanna Gilioli da Costa Nunes da Costa Nunes
NSNatasha Monte da Silva
Natasha Monte da Silva
JBJoão Victor Souza de Barros
João Victor Souza de Barros
NSNey Santos
Ney Santos
Introducción: El cáncer de páncreas es una de las neoplasias malignas más agresivas, ocupando el duodécimo lugar entre los cánceres más comunes, y la sexta causa principal de muertes relacionadas con el cáncer a nivel mundial. Su etiología es multifactorial, involucrando factores genéticos y no genéticos. Objetivo: Investigar la relación entre los datos epidemiológicos sobre la incidencia y mortalidad global del cáncer de páncreas y variaciones genéticas específicas conocidas como polimorfismos de un solo nucleótido (SNP). Método: Se analizaron 253 SNP, identificados a través de estudios de asociación del genoma completo (GWAS). Las frecuencias alélicas se obtuvieron de bases de datos de poblaciones globales. Utilizando el análisis de correlación de Pearson, se evaluaron las relaciones entre las frecuencias de los SNP, la incidencia y las tasas de mortalidad. Resultados: Los resultados identificaron 16 SNP significativos (p<0,05), entre los cuales rs2816938, rs372883 y rs2236575 fueron altamente significativos (p<0,001). Estas variantes se asociaron principalmente con tasas de mortalidad más elevadas, particularmente en poblaciones europeas y americanas, mientras que las poblaciones africanas y del Sudeste Asiático mostraron frecuencias de SNP más bajas y tasas de mortalidad más reducidas. Los hallazgos sugieren que la predisposición genética desempeña un papel crucial en la susceptibilidad y progresión del cáncer de páncreas. Conclusión: La correlación entre las frecuencias de SNP y los datos epidemiológicos refuerza la influencia de los factores de riesgo genéticos específicos de cada población, destacando la importancia de enfoques personalizados en las estrategias de detección, prevención y tratamiento.